Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,820 | 36,375 | 66,137 | 34,855 | 15,647 |
| Receivables | 45,440 | 52,143 | 67,944 | 46,717 | 25,681 |
| Inventories | 5,396 | 7,775 | 10,035 | 10,479 | 13,810 |
| Income taxes - deferred | N/A | N/A | N/A | 6,544 | 9,301 |
| Other current assets | 0 | 0 | 0 | 4,723 | 4,749 |
| TOTAL | $93,771 | $108,910 | $155,690 | $119,868 | $76,385 |
| Non-Current Assets | |||||
| PPE Net | 752 | 1,103 | 2,346 | 1,514 | 6,872 |
| Intangibles | 108,706 | 200,171 | 340,808 | 345,389 | 122,519 |
| Other Non-Current Assets | 2,263 | 257 | 347 | 11,253 | 5,610 |
| TOTAL | $111,721 | $201,531 | $343,501 | $358,156 | $135,001 |
| Total Assets | $205,492 | $310,441 | $499,191 | $478,024 | $211,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,345 | 17,000 |
| Accounts payable and accrued liabilities | 18,523 | 18,172 | 25,984 | 15,558 | 3,591 |
| Accrued Expenses | 68,966 | 75,029 | 76,369 | 71,510 | 43,475 |
| Other current liabilities | 2,648 | 5,224 | 16,755 | 3,264 | 5,402 |
| TOTAL | $93,801 | $109,528 | $132,443 | $97,677 | $69,468 |
| Non-Current Liabilities | |||||
| Long Term Debt | 214,244 | 186,250 | 15,000 | 220,000 | 1,310 |
| Other Non-Current Liabilities | 71,704 | 128,726 | 318,449 | 76,755 | 14,386 |
| TOTAL | $285,948 | $314,976 | $333,651 | $296,755 | $31,195 |
| Total Liabilities | $379,749 | $424,504 | $466,094 | $394,432 | $100,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,873 | 10,016 | 6,113 | 3,839 | 3,735 |
| Common Shares | 119 | 100 | 61 | 383 | 372 |
| Retained earnings | -435,534 | -358,393 | -188,803 | -40,488 | -5,202 |
| Other shareholders' equity | 0 | -79 | 452 | -431 | -1 |
| TOTAL | $-174,257 | $-114,063 | $33,097 | $83,592 | $110,723 |
| Total Liabilities And Equity | $205,492 | $310,441 | $499,191 | $478,024 | $211,386 |